Close Menu
USA Biz News Stay Current on Economy News
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Realtor
    • Entrepreneur
    • Journalist
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Economy
  • Life Style
Trending
  • Mr. Eric Y.S.: Anchoring Truth, Purpose, and Impact Through Storytelling
  • From Quiet Beginnings to Purpose-Driven Impact: The Inspiring Journey of Sarah Grace
  • The Journey of Danny B Musique: A Symphony of Passion, Perseverance, and Purpose
  • Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.
  • The U.S. government is thinking about making a website, maybe even with Trump’s name on it, to help people find cheaper medicine.
  • Stocks Pop After Interest Rate Decrease: Great or Just for Wall Street?
  • Trump’s Policies Put Clean Energy Jobs in Danger.
  • Is America Headed Back to a McCarthy Era?   
USA Biz News Stay Current on Economy News
Tuesday, March 10
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Realtor
    • Entrepreneur
    • Journalist
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Economy
  • Life Style
USA Biz News Stay Current on Economy News
Home » News » Eternal (Zomato) shares recover despite 78% decline in Q4 profit, should you buy?

Eternal (Zomato) shares recover despite 78% decline in Q4 profit, should you buy?

Jessica BrownBy Jessica Brown Business
Share
Facebook Twitter LinkedIn Pinterest Email

Eternal shares erased the early loss by pushing the purchase recommendations of stockbrokers despite the cautious tone after the 78 percent fall in the net gain of the fourth quarter in March 2025.

The Eternal Matrix, Zomato and Blinkit company registered a net consolidated benefit of ₹ 39 million rupees in said quarter compared to ₹ 175 million rupees in the corresponding period of the previous prosecutor. The consolidated revenues of the operations increased 64 percent to ₹ 5,833 million rupees.

The institutional actions of Nuvama declared that Blinkit reported lower losses of hope despite an accelerated rhythm of additions of the dark store in the fourth quarter. However, the contribution margin improved, also with the dilution of newly opened dark stores.

By adding that Ebidta losses would decrease from the next quarter, Nuvama maintained the purchase recommendation at a reduced objective price of ₹ 300 to ₹ 290.

Nomura has maintained the purchase at a revised objective price of ₹ 280 of ₹ 290. Jefferies has also cut the target price to ₹ 250, maintaining retention. Morgan Stanley kept overweight at an objective price of ₹ 290.

Motilal Oswal reiterated the purchase at an objective price of ₹ 260, observing that Zomato Expetza the competition to increase both in rapid and non -grrelyal trade (QC), including the pressure of the players the next day that accelerate their speeds.

Motilal has reduced estimates for FY26/27 by 52 percent/27 percent, due to the uncertainty that arises from intense competition and accelerated expansion of the dark store network. “This expansion has led to a reduction in profitability due to incredible investments,” he added.

Eternal actions increased 2.92 percent to ₹ 239.31 in the NSE at 10.42 am, near the maximum intradic of ₹ 239.44. The action opened lower than ₹ 220.05.

More like this

Posted on May 2, 2025

Previous ArticleF1 Miami Grand Prix: Fernando Alonso talks Aston Martin’s present, and future, Thursday in Miami
Next Article 5/1: CBS Evening News – CBS News

Keep Reading

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

Trump’s Policies Put Clean Energy Jobs in Danger.

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

Should Companies Ditch Quarterly Earnings Reports? Trump Thinks So.

People in the U.S. Are Feeling Less Hopeful in September: What It Means.

The Treasury Secretary Warns: Canceling Tariffs Could Be Really Expensive.

Most View

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

September 20, 2025

Trump’s Policies Put Clean Energy Jobs in Danger.

September 19, 2025

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

September 18, 2025
Latest Posts

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

September 20, 2025

Trump’s Policies Put Clean Energy Jobs in Danger.

September 19, 2025

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

September 18, 2025

Should Companies Ditch Quarterly Earnings Reports? Trump Thinks So.

September 16, 2025

USA

  • World
  • Politics
  • Economy
  • Life Style

Business

  • CEO
  • Realtor
  • Entrepreneur
  • journalist

Sports

  • Athlete
  • Coach
  • Fitness Trainer

Health

  • Doctor
  • Plastic Surgeon
  • Beauty Cosmetics
© 2017-2026 usabiznews. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.